Loading...

Centessa Pharmaceuticals plc

CNTA•NASDAQ
Healthcare
Biotechnology
$39.47
$0.04(0.10%)
U.S. Market opens in 49h 27m

Centessa Pharmaceuticals plc (CNTA) Stock Overview

Explore Centessa Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.9B
P/E Ratio-27.12
EPS (TTM)$-1.46
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 Month$23.17
3 Months$23.20
1 Year Target$30.14

CNTA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Centessa Pharmaceuticals plc (CNTA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.92, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $30.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -27.12 and a market capitalization of 5.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.10%
5-Day Change
-0.28%
1-Month Change
41.52%
3-Month Change
56.19%
6-Month Change
63.44%
Year-to-Date (YTD) Change
57.82%
1-Year Change
190.007%
3-Year Change
725.73%
5-Year Change
81.47%
All-Time (Max) Change
81.47%

Contact Information

https://www.centessa.com
44 203 9206789
1 Ashley Road, Altrincham, NaN, WA14 2DT

Company Facts

77 Employees
IPO DateMay 28, 2021
CountryGB
Actively Trading

Frequently Asked Questions